|
|
Research on anti-inflammatory and immune effects of quercetin and its partial mechanism |
SI Lijun WANG Xue WANG Linlin HUANG Hua |
Xinjiang Institute of Materia Medica, Xinjiang Uygur Autonomous Region, Urumqi 830004, China |
|
|
Abstract Objective To investigate the anti-inflammatory and immune effects of quercetin and its partial mechanism. Methods Different concentrations of quercetin were used to intervene RAW 264.7 cells to observe the effects of quercetin on the viability of RAW 264.7 cells. Quercetin with no influence on the viability of RAW 264.7 cells was selected for further study. Untreated RAW 264.7 cells were used as blank group, and the inflammatory cell model was established by stimulating RAW 264.7 cells with 1 μg/ml lipopolysaccharide (LPS). The cells were divided into model group, quercetin 0.98, 1.95, 3.90, and 7.80 μg/ml dose groups. Cell viability, reactive oxygen species (ROS), and monocyte chemoattractant protein 1 (MCP1) levels were observed. The cyclooxygenase (COX)-1 and COX-2 inhibitor screening kit was used to detect the inhibition of quercetin on COX-1 and COX-2. In addition, 20 SPF BALB/C male mice (6-8 weeks old, 18-22 g body weight) were selected to prepare splenic lymphocyte suspension, and different concentrations of quercetin were used to interfere with the splenic lymphocytes of mice, and the effects of quercetin on cell proliferation were observed. Mice spleen lymphocytes were respectively treated with LPS (10 μg/ml) or concanavalin A (Con A) (8 μg/ml) were divided into LPS group, Con A group, and quercetin 0.98, 1.95, 3.90, 7.80 μg/ml groups. The effects of different concentrations of quercetin on the proliferation of spleen lymphocytes, T cells induced by Con A and B cells induced by LPS, and the levels of tumor necrosis factor -α (TNF-α), interleukin-6 (IL-6) and interferon γ (INF-γ) in T cells were observed. Results When quercetin < 7.8 μg/ml, there was no significant difference in the activity of RAW 264.7 cells compared with untreated cells (P > 0.05). The levels of ROS and MCP1 in quercetin 0.98, 1.95, 3.90, and 7.80 μg/ml groups were lower than those in model group, and the difference was highly statistically significant (P < 0.01). The IC50 of quercetin to COX-1, COX-2 were 12.73 and 0.44 μg/ml, respectively, and the IC50 ratio of COX-2 to COX-1 was 0.034. The proliferation of spleen lymphocytes of mice with quercetin concentration of 0.98, 1.95, 3.90, and 7.80 μg/ml were higher than those without quercetin, and the differences were statistically significant (P < 0.05 or P < 0.01). T cells in quercetin 1.95, 3.90, and 7.80 μg/ml dose groups were lower than those in Con A group, and B cells in quercetin 3.90 and 7.80 μg/ml dose groups were lower than those in LPS group, with statistical significance (P < 0.05). The levels of TNF-α in quercetin 1.95, 3.90, and 7.80 μg/ml groups were lower than those in Con A group, the leves of IL-6 and INF-γ in quercetin dose groups were lower than those in Con A group, and the differences were highly statistically significant (P < 0.01). Conclusion Quercetin is a selective COX-2 inhibitor with good anti-inflammatory activity, which can promote the proliferation of splenic lymphocytes in mice, inhibit the proliferation of T and B cells and the secretion of cytokines.
|
|
|
|
|
[1] 任改艳,张步有,黄剑林.槲皮素对LPS诱导小鼠RAW264.7细胞炎症的保护作用[J].中成药,2019,41(8):1795-1799.
[2] 冯亚莉,卢令攀,翟广玉.槲皮素衍生物抗肿瘤活性研究进展[J].中国中药杂志,2020,45(15):3565-3574.
[3] 李阳,苏艳瑜,李国豪,等.槲皮素通过Nrf2通路对糖尿病大鼠胰腺氧化损伤的拮抗作用机制[J].食品科学,2021, 42(5):208-214.
[4] 张红娜,周玉法,刘敬博,等.基于NF-κB和Nrf2信号通路探讨槲皮素的护肝功效及其作用机理[J].西北农业学报,2020,29(1):143-149.
[5] 李煊,许子贤,明艳林.中草药在防治新型冠状病毒肺炎中的应用[J].亚热带植物科学,2020,49(2):83-92.
[6] 赵艳,郑彩霞,万秋园,等.槲皮素与FSCN1基因siRNA联合对卵巢癌生长抑制及免疫功能的影响研究[J].临床和实验医学杂志,2018,17(18):1947-1951.
[7] 张倩.新疆一枝蒿有效成分的提取分析及免疫活性研究[D].乌鲁木齐:新疆大学,2014.
[8] Wang X,Huang H,Ma XP,et al. Anti-inflammatory effects and mechanism of the total flavonoids from Artemisia scoparia Waldst. et kit. in vitro and in vivo [J]. Biomed Pharmacother,2018,104:390-403.
[9] 杨璐铭,陈虎彪,郭乔如,等.雪莲的化学成分及药理作用研究进展[J].药学学报,2020,55(7):1466-1477.
[10] 郭艳丽,刘维丽,鞠爱霞,等.基于网络药理学的金莲花活性成分抗炎机制研究[J].中医药学报,2020,48(8):25-28.
[11] 王玮,吴萌,司明东,等.基于主成分分析法的不同产地金莲花药材品质评价[J].精细与专用化学品,2020,28(11):32-39.
[12] 陈燕玲.沙棘药用成分的研究及其活性初步探讨[D].无锡:江南大学,2017.
[13] 宋海龙.大果沙枣果实性状及化学成分与质量标准的研究[D].乌鲁木齐:新疆农业大学,2015.
[14] 刘明月.槲皮素抑制脂多糖诱导的RAW264.7细胞炎症反应机制及其与AMPK的关系[D].大连:辽宁师范大学,2018.
[15] 王程,窦文芳,何丽丽.微生物糖基转移酶催化合成槲皮素糖苷及其抗炎活性评价[J].生物技术进展,2020, 10(2):170-175.
[16] 邹凯.黄酮类药物对巨噬细胞中NLRP3信号通路的调控及缓解DSS诱导的小鼠结肠炎机制的研究[D].呼和浩特:内蒙古农业大学,2018.
[17] 田瑞雪,孙耀宗,姚有昊,等.槲皮素对免疫低下小鼠免疫功能的影响[J].中国现代医药杂志,2019,21(9):13-16.
[18] 徐佳,夏伯候,邓静,等.妇科千金胶囊对小鼠脾淋巴细胞免疫活性的研究[J].湖南中医药大学学报,2020,40(11):1320-1326.
[19] 黎勇.罗汉果苷V在RAW264.7细胞中抑制炎症分子机制的研究[D].长沙:湖南农业大学,2019.
[20] 汪晨净,裴淑燕,南晓东,等.内皮素-1对大鼠血管平滑肌细胞产生MCP-1的影响及其机制[J].中国应用生理学杂志,2018,34(3):283-288.
[21] 龚姗,李弘,刘叶倩,等.复方七芍降压片对TNF-α诱导的与平滑肌细胞共培养的血管内皮细胞中炎症因子与AP-1、MCP-1蛋白表达的影响[J].中国实验动物学报,2020,28(6):733-741.
[22] 闫文丽,马宏跃,吴德康,等.应用UPLC-MS/MS探讨芫花酯甲对巨噬细胞分泌花生四烯酸类水平的影响[J].中国实验方剂学杂志,2015,21(10):94-98.
[23] 任越,姚美村,霍晓乾,等.抗新型冠状病毒方剂基于花生四烯酸代谢通路防治“细胞因子风暴”的研究[J].中国中药杂志,2020,45(6):1225-1231.
[24] 高秀清.环氧酶-2抑制剂的临床应用及研究进展评价[J].中国医院用药评价与分析,2007,7(1):20-22.
[25] Hushmendy S,Jayakumar L,Hahn AB,et al. Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation [J]. Nutr Res,2009,29(8):568-578. |
|
|
|